Jefferies analyst Michael Toomey initiates coverage on Beta Bionics, Inc. (NASDAQ: BBNX) with a Buy rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage